231 related articles for article (PubMed ID: 35413401)
1. The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression.
Wang G; Duan J; Pu G; Ye C; Li Y; Xiu W; Xu J; Liu B; Zhu Y; Wang C
Biochim Biophys Acta Mol Basis Dis; 2022 Aug; 1868(8):166413. PubMed ID: 35413401
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.
Schulien I; Hockenjos B; Schmitt-Graeff A; Perdekamp MG; Follo M; Thimme R; Hasselblatt P
Cell Death Differ; 2019 Sep; 26(9):1688-1699. PubMed ID: 30778201
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis.
Zhu C; Kim K; Wang X; Bartolome A; Salomao M; Dongiovanni P; Meroni M; Graham MJ; Yates KP; Diehl AM; Schwabe RF; Tabas I; Valenti L; Lavine JE; Pajvani UB
Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463916
[TBL] [Abstract][Full Text] [Related]
5. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.
Du M; Wang X; Yuan L; Liu B; Mao X; Huang D; Yang L; Huang K; Zhang F; Wang Y; Luo X; Wang C; Peng J; Liang M; Huang D; Huang K
J Hepatol; 2020 Dec; 73(6):1333-1346. PubMed ID: 32717288
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.
Syn WK; Choi SS; Liaskou E; Karaca GF; Agboola KM; Oo YH; Mi Z; Pereira TA; Zdanowicz M; Malladi P; Chen Y; Moylan C; Jung Y; Bhattacharya SD; Teaberry V; Omenetti A; Abdelmalek MF; Guy CD; Adams DH; Kuo PC; Michelotti GA; Whitington PF; Diehl AM
Hepatology; 2011 Jan; 53(1):106-15. PubMed ID: 20967826
[TBL] [Abstract][Full Text] [Related]
7. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
[TBL] [Abstract][Full Text] [Related]
8. The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis.
Feng Y; Li W; Wang Z; Zhang R; Li Y; Zang L; Wang P; Li Z; Dong Y
J Transl Med; 2022 Nov; 20(1):497. PubMed ID: 36324154
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression.
Ma F; Liu Y; Hu Z; Xue Y; Liu Z; Cai G; Su W; Zheng Z; Fang X; Yan X; Ding D; Sun X; Jiang Y; Wei S; Li W; Zhao J; Zhang H; Li H; Xiao D; Zhang C; Ying H; Qin J; Gao X; Dai X; Fu W; Xu Y; Li Y; Cui A
Hepatology; 2023 Nov; 78(5):1492-1505. PubMed ID: 36680394
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor CCR1 regulates macrophage activation through mTORC1 signaling in nonalcoholic steatohepatitis.
Li H; Pan T; Gao L; Ding R; Yu Y; Ma M; Wang Y; Jin S; Chen Y; Ding C; Xu L
Metabolism; 2024 Feb; 151():155758. PubMed ID: 38070823
[TBL] [Abstract][Full Text] [Related]
11. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.
Zhang X; Li S; Zhou Y; Su W; Ruan X; Wang B; Zheng F; Warner M; Gustafsson JÅ; Guan Y
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3181-3185. PubMed ID: 28270609
[TBL] [Abstract][Full Text] [Related]
12. Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model.
Thapaliya S; Wree A; Povero D; Inzaugarat ME; Berk M; Dixon L; Papouchado BG; Feldstein AE
Dig Dis Sci; 2014 Jun; 59(6):1197-206. PubMed ID: 24795036
[TBL] [Abstract][Full Text] [Related]
13. IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis.
Gao Y; Liu Y; Yang M; Guo X; Zhang M; Li H; Li J; Zhao J
Oncotarget; 2016 Jun; 7(23):33649-61. PubMed ID: 27172901
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-derived Osteopontin (SPP1) Protects From Nonalcoholic Steatohepatitis.
Han H; Ge X; Komakula SSB; Desert R; Das S; Song Z; Chen W; Athavale D; Gaskell H; Lantvit D; Guzman G; Nieto N
Gastroenterology; 2023 Jul; 165(1):201-217. PubMed ID: 37028770
[TBL] [Abstract][Full Text] [Related]
15. Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling.
Li Y; Xiu W; Xu J; Chen X; Wang G; Duan J; Sun L; Liu B; Xie W; Pu G; Wang Q; Wang C
JCI Insight; 2022 Dec; 7(23):. PubMed ID: 36477358
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
17. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
19. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.
Machado MV; Michelotti GA; Xie G; Almeida Pereira T; Boursier J; Bohnic B; Guy CD; Diehl AM
PLoS One; 2015; 10(5):e0127991. PubMed ID: 26017539
[TBL] [Abstract][Full Text] [Related]
20. A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice.
Zheng S; Yang W; Yao D; Tang S; Hou J; Chang X
Ann Med; 2022 Dec; 54(1):2233-2245. PubMed ID: 35950602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
